Central nervous system relapse in adults with acute lymphoblastic leukemia.
about
Central nervous system disease in hematologic malignancies: historical perspective and practical applications.Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidLiposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemia.Central nervous system involvement in adult acute lymphoblastic leukemia.Leukaemias into the 21st century: part 1: the acute leukaemias.Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma.Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.Secondary glioma following acute lymphocytic leukemia: therapeutic implications.Neurological Complications of the Leukemias Across the Ages.Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults.Unilateral optic nerve infiltration as an initial site of relapse of acute lymphoblastic leukemia in remission.Relapsed T-cell acute lymphoblastic leukaemia in the vitreous of an adult: a case reportMorphologic detection of blast cells in the cerebrospinal fluid at diagnosis of adult acute lymphoblastic leukemia appears to be associated with adverse prognosis.Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.Flow cytometric analysis of cerebrospinal fluid in adult patients with acute lymphoblastic leukemia during follow-up.Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse.Low-dose cranial boost in high-risk adult acute lymphoblastic leukemia patients undergoing bone marrow transplant.
P2860
Q33585849-EC5629D3-D0A6-448A-8FC7-C74743DDC8BCQ33841347-A9EC8EDE-BA10-4F4A-B127-E9CFCBDE358EQ34543015-1E3D7E4D-37E4-4010-9AFD-F769A5AF5440Q35563658-2C8686EF-84F4-45DA-B995-00195156F58AQ36157608-C42996FB-E71F-4D75-B8DB-1B4BA5BD6C28Q37293534-AC5AF7E9-BB51-4E70-B4BB-0043714ACD6DQ38060223-2261DD15-3BE5-493C-9AD1-E86802AFC2BBQ38153477-F95796FD-79B6-4982-9205-1E3F226FD3F5Q38269513-63101CFD-A8C7-4D84-B969-568A7A775203Q38829784-136869DC-178D-4B19-89CB-0E1D0E4B2218Q39147519-848B0ED4-C3A8-4F9E-B53B-C7FDAD904259Q39296772-9FE05F39-7C1F-46E2-9753-906B59B30988Q41504955-EDD85BEC-CAA6-434D-B2EA-1EBABC38E465Q42795610-FFF21457-7F5F-49D3-8176-3A61C0818E32Q43666664-05C8226F-2199-4A96-9014-9DD5A5A362DAQ44313276-C398F97E-5EA1-4E2C-BD90-3BA1F319E1A9Q44772522-EE7FCC78-011A-4D83-A468-3B57280A06F3Q48118279-AD4ADD73-01C9-4C54-879F-6740BF472152Q52590712-EB3E2064-E1C1-491B-A5ED-C8D14A86BF21Q53452790-F171060C-B624-4AD8-9136-7AD7FF14B1A0
P2860
Central nervous system relapse in adults with acute lymphoblastic leukemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Central nervous system relapse in adults with acute lymphoblastic leukemia.
@en
type
label
Central nervous system relapse in adults with acute lymphoblastic leukemia.
@en
prefLabel
Central nervous system relapse in adults with acute lymphoblastic leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Central nervous system relapse in adults with acute lymphoblastic leukemia.
@en
P2093
Charles Koller
Deborah Thomas
Francis J Giles
Usha R Surapaneni
P2860
P304
P356
10.1002/CNCR.10265
P407
P577
2002-02-01T00:00:00Z